Ceralasertib: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Ceralasertib

• A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
  NCT04550104 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
  NCT04090567 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
  NCT06680050 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel
  NCT05582538 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
  NCT06769126 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 148 locations

Common questions

How many recruiting trials involve Ceralasertib?

5 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.